Proinflammatory Cytokine Release and Infusional Side-Effects after Anti-Thymocyte Globulin Serotherapy for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

被引：0
|
作者：
Khanolkar, Rutvij A. [1 ]
Dookie, Stephanie [1 ]
Li, Na [2 ]
Khan, Faisal [3 ]
Storek, Jan [4 ]
机构：
[1] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[3] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada
[4] Univ Calgary, Dept Med, Calgary, AB, Canada
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189653
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease
    Khanolkar, Rutvij A.
    Tripathi, Gaurav
    Dharmani-Khan, Poonam
    Dabas, Rosy
    Kinzel, Megan
    Kalra, Amit
    Puckrin, Robert
    Jimenez-Zepeda, Victor
    Jamani, Kareem
    Duggan, Peter R.
    Chaudhry, Ahsan
    Bryant, Adam
    Stewart, Douglas A.
    Khan, Faisal M.
    Storek, Jan
    [J]. CYTOTHERAPY, 2022, 24 (12) : 1225 - 1231
  • [42] Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation
    Teramoto, Masahiro
    Maruyama, Satoshi
    Tamaki, Hiroya
    Kaida, Katsuji
    Mayumi, Azusa
    Fukunaga, Keiko
    Inoue, Takayuki
    Yoshihara, Kyoko
    Yoshihara, Satoshi
    Ikegame, Kazuhiro
    Okada, Masaya
    Osugi, Yuko
    Ogawa, Hiroyasu
    Higasa, Satoshi
    Morita, Kunihiko
    Matsumoto, Kana
    Kijima, Takashi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (02) : 248 - 257
  • [43] Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
    van Lier, Yannouck F.
    Vos, Jael
    Blom, Bianca
    Hazenberg, Mette D.
    [J]. GUT MICROBES, 2023, 15 (01)
  • [44] Reduced Acute Graft-Versus Host Disease Incidence in Patients Receiving Anti-T Lymphocyte Globulin in Comparison to Anti-Thymocyte Globulin For The Prophylaxis of Graft-Versus-Host Disease After ALLO-HSCT
    Campidelli, Arnaud
    D'Aveni-Piney, Maud
    Moulin, Charline
    Detrait, Marie
    Boulange, Laura
    Roth-Guepin, Gabrielle
    Tarillon, Sylvie
    Hottier, Nathalie
    Jeulin, Helene
    Verstraete, Emma
    Notarantonio, Anne Beatrice
    Feugier, Pierre
    Rubio, Marie T.
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 84 - 85
  • [45] Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria
    Knaus, Hanna A.
    Rottner, Theresa
    Baumann, Clara K.
    Cserna, Julia
    Mitterbauer, Margit
    Schulenburg, Axel
    Rabitsch, Werner
    Wohlfarth, Philipp
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 260.e1 - 260.e9
  • [46] Partial T-Cell Depletion By Low-Dose Anti-Thymocyte Globulin to Reduce Severe Acute and Chronic Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
    Imataki, Osamu
    Ohbayashi, Yumiko
    Ohue, Yukiko
    Matsuka, Harumi
    Uemura, Makiko
    Kadowaki, Norimitsu
    [J]. BLOOD, 2015, 126 (23)
  • [47] Role of Anti-Lymphocyte Globulin in Prophylaxis of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation in Patients with Acute Leukemia
    Wakamatsu, Manabu
    Uchida, Naoyuki
    Ohashi, Kazuteru
    Fukuda, Takahiro
    Kanamori, Heiwa
    Ozawa, Yukiyasu
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Murata, Makoto
    Kato, Koji
    Atsuta, Yoshiko
    Teshima, Takanori
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S71 - S71
  • [48] Outcomes of unrelated donor stem cell transplantation with or without anti-thymocyte globulin used as graft-versus-host disease prophylaxis in patients with acute leukaemia and myelodysplastic syndrome
    Gener, Georgina
    Batlle, Montserrat
    Morgades, Mireia
    Jimenez, Maria-Jose
    Ferra, Christelle
    Ribera, Josep-Maria
    [J]. MEDICINA CLINICA, 2021, 157 (08): : 380 - 384
  • [49] High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation
    Lim, Andrew Boon Ming
    Storek, Jan
    Beligaswatte, Ashanka
    Collins, Marnie
    Mason, Kate
    Li, Emily Peizhen
    Chaudhry, Ahsan
    Russell, James A.
    Daly, Andrew
    Szer, Jeffrey
    Lewis, Ian
    Ritchie, David Stuart
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S334 - S334
  • [50] Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation
    Tandra, Anand
    Covut, Fahrettin
    Cooper, Brenda
    Creger, Richard
    Brister, Lauren
    McQuigg, Bernadette
    Caimi, Paolo
    Malek, Ehsan
    Tomlinson, Ben
    Lazarus, Hillard M.
    Otegbeye, Folashade
    Kolk, Merle
    de Lima, Marcos
    Metheny, Leland
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1644 - 1651
12345